A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)

Clinical trial NCT04487431 · COMPLETED

Trial details

NCT number: NCT04487431
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Endometriosis Related Pain Overactive Bladder Diabetic Neuropathic Pain Refractory or Unexplained Chronic Cough

Start date: 2020-08-05
Primary completion: 2020-09-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.